Skip to Content

Green Hygienics Inc GRHY

Morningstar Rating
$0.01 −0.02 (72.73%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

GRHY is trading at a 828% premium.
Price
$0.01
Fair Value
$2.53
Uncertainty
Extreme
1-Star Price
$2.36
5-Star Price
$9.42
Economic Moat
Zwmzk
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if GRHY is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.02
Day Range
$0.010.01
52-Week Range
$0.010.02
Bid/Ask
$0.01 / $0.98
Market Cap
$327,945.01
Volume/Avg
151 / 147

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Green Hygienics Inc through its owned subsidiary, Nude Nicotine, Inc is engaged in manufacturing, distribution and wholesale of variety of commodities including electronic e-liquid products. It is also a research and development laboratory, and product developer of smoking cessation products centered around its technologies related to the production and use of nicotine.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Total Number of Employees

Valuation

Metric
GRHY
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
GRHY
Quick Ratio
Current Ratio
Interest Coverage
Quick Ratio
No chart available

Profitability

Metric
GRHY
Return on Assets (Normalized)
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
No chart available
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Zoetis Inc Class A
ZTS
VqmrcvrbQcph$82.5 Bil
Merck KGaA ADR
MKKGY
TrdtxfzbTnmmcpx$73.2 Bil
Haleon PLC ADR
HLN
QhhbznrqVhqkr$41.0 Bil
Teva Pharmaceutical Industries Ltd ADR
TEVA
PcqyrsppPdjkz$19.2 Bil
Viatris Inc
VTRS
DqxbshwnBxwpz$14.0 Bil
Dr Reddy's Laboratories Ltd ADR
RDY
LhzmzrtxgLtgl$13.6 Bil
Catalent Inc
CTLT
WhjdvggrhDjkryt$10.6 Bil
Perrigo Co PLC
PRGO
VvdwbqwGplz$3.8 Bil
Prestige Consumer Healthcare Inc
PBH
WtfhxybpGrcqm$3.5 Bil
Curaleaf Holdings Inc
CURLF
YzddwnlzpBpss$3.0 Bil

Sponsor Center